AddThis

Cerberus Capital Management in negotiations for Supervalu business

MINNEAPOLIS — Supervalu on Friday confirmed that a previously announced review of strategic alternatives is proceeding, sparking a slight run on the company's stock. As of early Monday afternoon, Supervalu was trading at $2.53 per share, up 6.3%. 

"The company continues to be in active discussion with several parties," Supervalu stated. 

The Wall Street Journal on Sunday reported that Cerberus Capital Management and Supervalu had been negotiating a potential acquisition deal through the weekend.

However, Bloomberg News had reported earlier those talks may have stalled because Cerberus is having difficulty raising the capital for a leveraged buyout. 

 

© 2014 Drug Store News. All Rights Reserved.